Skip to content

Addiction: all studies

Page 574 of 860: studies 5,731 to 5,740 of 8,594, newest first. Back to the addiction overview

Research

“Polytox” synthetic cathinone abuse: A potential role for organic cation transporter 3 in combined cathinone-induced efflux

Neurochemistry International September 22, 2018 Felix P. Mayer, Diethart Schmid, Marion Holy et al. 15 citations

Synthetic cathinone derivatives are a new class of psychoactive substances (NPS), also known as “bath salts”, designed to exert psychostimulant effects resembling those of well-known psychostimulants, such as cocaine and 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”). As major constituents of bath salts, the cathinone derivatives 3,4-methylenedioxypyrovalerone (MDPV) and...

On the safety of repeated ketamine infusions for the treatment of depression: Effects of sex and developmental periods

Neurobiology of Stress September 21, 2018 Caroline E. Strong, Mohamed Kabbaj 60 citations

In this review, we will discuss the safety of repeated treatments with ketamine for patients with treatment-resistant depression (TRD), a condition in which patients with major depression do not show any clinical improvements following treatments with at least two antidepressant drugs. We will discuss the effects of these treatments in both sexes at different developmental periods. Numerous...

Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age

Frontiers in Immunology September 21, 2018 José A. Crippa, Francisco Silveira Guimarães, Alline Cristina Campos et al. 312 citations

Background: Among the many cannabinoids in the cannabis plant, cannabidiol (CBD) is a compound that does not produce the typical subjective effects of marijuana. Objectives: The aim of the present review is to describe the main advances in the development of the experimental and clinical use of cannabidiol CBD in neuropsychiatry. Methods: A non-systematic search was performed for studies...

Richard Avenarius’ “Kritik Der Reinen Erfahrung” (Critique of Pure Experience): An English Summary

Preprints.org September 20, 2018 Arturo Tozzi 1 citation preprint

The French-Swiss Professor in inductive philosophy Richard Avenarius (1843-1896), the father of empirio-criticism together with Ernst Mach, is one of the most underrated and misunderstood philosophers ever. It mostly depends upon his terminology, which displays an insurmountable difficulty. However, influenced by the most innovative proposals of his times of transition between the...

Psychoplastogens: A Promising Class of Plasticity-Promoting Neurotherapeutics.

Journal of experimental neuroscience September 19, 2018 David E. Olson

Neural plasticity-the ability to change and adapt in response to stimuli-is an essential aspect of healthy brain function and, in principle, can be harnessed to promote recovery from a wide variety of brain disorders. Many neuropsychiatric diseases including mood, anxiety, and substance use disorders arise from an inability to weaken and/or strengthen pathologic and beneficial circuits,...

A Phenomenological Discussion of Early Imitation

Phenomenology and Mind September 17, 2018 Andrea Zhok

The following pages are devoted to an attempt to examine Andrew Meltzoff’s discoveries concerning neonatal imitation in the light of Husserl’s discussion of Fremderfahrung. We criticise Meltzoff’s explanatory model AIM (Active Intermodal Mapping), which is introduced to account for his empirical findings, for two main reasons. First, the AIM model does not seem to properly reconcile the...

DOI: 10.13128/phe_mi-19605 (opens in new tab) Full text (opens in new tab) Husserl Meltzoff Imitation Cross-modal identity

Affectivity and Self-Displacement in Stein’s Early Phenomenology On the Role of Self-Experience in Empathy

Phenomenology and Mind September 17, 2018 Elisa Magrì 1 citation

In this paper, I shall focus on the role of bodily self-displacement in Stein’s account of empathy, pointing out its relevance in the general dimension of affectivity. In my view, Stein grounds empathy on a dynamic model of embodied self-experience, which shares significant similarities with Varela & Depraz’s neurophenomenology. However, I shall argue that Stein’s view of empathy cannot be...

Dopaminergic neurotoxic effects of 3-TFMPP derivatives.

Life Sciences September 15, 2018 Mohammed Majrashi, Mohammed Almaghrabi, Maali Fadan et al.

Designer drugs are synthetically formulated to mimic the psychostimulatory effects of an original controlled/illegal drug of abuse. Designer drugs have similar chemical structure or functional analog as compared to existing controlled psychostimulatory drugs. There is a substantial rise in the production and use of designer drugs globally. Piperazine designer drugs were synthesized as an...

DOI: 10.1016/j.lfs.2018.07.052 (opens in new tab) Full text (opens in new tab) Designer drugs Dopamine Mechanisms of toxicity Neurotoxicity +2

Interaction Model of Brain and Consciousness

The Spontaneous Brain September 14, 2018 Georg Northoff

In addition to the spectrum model, I also introduced an interaction model to characterize the brain’s neural activity (chapter 2). Is the interaction model of brain also relevant for consciousness? That is the focus in the present chapter. I here present various lines of empirical evidence focusing on disorders of consciousness like vegetative state, anesthesia, and sleep. Based on empirical...

DARK Classics in Chemical Neuroscience: Ibogaine

ACS Chemical Neuroscience September 14, 2018 Michael Wasko, Paula A. Witt‐enderby, Christopher K. Surratt 63 citations

The West African iboga plant has been used for centuries by the Bwiti and Mbiri tribes to induce hallucinations during religious ceremonies. Ibogaine, the principal alkaloid responsible for iboga's psychedelic properties, was isolated and sold as an antidepressant in France for decades before its adverse effects precipitated its removal from the market. An ibogaine resurgence in the 1960s was...

DOI: 10.1021/acschemneuro.8b00294 (opens in new tab) Hallucinogen Nicotine Synthetic cannabinoids Nicotinic acetylcholine receptor +2